IN185384B - - Google Patents
Info
- Publication number
- IN185384B IN185384B IN1499DE1996A IN185384B IN 185384 B IN185384 B IN 185384B IN 1499DE1996 A IN1499DE1996 A IN 1499DE1996A IN 185384 B IN185384 B IN 185384B
- Authority
- IN
- India
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP19617495 | 1995-07-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN185384B true IN185384B (ja) | 2001-01-13 |
Family
ID=16353435
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1499DE1996 IN185384B (ja) | 1995-07-08 | 1996-07-05 |
Country Status (22)
Country | Link |
---|---|
US (1) | US5900488A (ja) |
EP (1) | EP0839035B1 (ja) |
KR (1) | KR100386491B1 (ja) |
CN (1) | CN1091596C (ja) |
AT (1) | AT407832B (ja) |
CA (1) | CA2226214C (ja) |
CH (1) | CH692045A5 (ja) |
DE (1) | DE19681478B4 (ja) |
DK (1) | DK176599B1 (ja) |
ES (1) | ES2137888B1 (ja) |
FI (1) | FI119357B (ja) |
GB (1) | GB2317615B (ja) |
HK (1) | HK1009751A1 (ja) |
IL (1) | IL122618A (ja) |
IN (1) | IN185384B (ja) |
LU (1) | LU90190B1 (ja) |
NO (1) | NO980055L (ja) |
NZ (1) | NZ311796A (ja) |
SE (1) | SE9800016D0 (ja) |
TW (1) | TW450969B (ja) |
WO (1) | WO1997002821A2 (ja) |
ZA (1) | ZA965745B (ja) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6127397A (en) * | 1996-12-10 | 2000-10-03 | Nihon Nohyaku Co., Ltd. | Optically active (R)-(E)-(4-substituted-phenyl-1,3-dithiolan-2-ylidene)-1-imidazolylaceto nitrile derivative, antifungal composition comprising the same, and method for producing the same |
JPWO2003105903A1 (ja) * | 2002-06-18 | 2005-10-13 | ポーラ化成工業株式会社 | 抗真菌医薬組成物 |
CA2489854A1 (en) | 2002-06-18 | 2003-12-24 | Pola Chemical Industries Inc. | Antifungal medicinal compositions |
EP2025337B1 (en) * | 2006-03-08 | 2014-09-10 | Nihon Nohyaku Co., Ltd. | Pharmaceutical composition for external use |
WO2007102243A1 (ja) * | 2006-03-08 | 2007-09-13 | Nihon Nohyaku Co., Ltd. | 外用の医薬組成物 |
RU2423128C2 (ru) * | 2006-03-08 | 2011-07-10 | Нихон Нохияку Ко., Лтд. | Фармацевтическая композиция для наружного применения |
WO2009028495A1 (ja) * | 2007-08-27 | 2009-03-05 | Nihon Nohyaku Co., Ltd. | 真菌性皮膚炎用剤 |
EP2191828B1 (en) | 2007-09-05 | 2016-08-10 | Pola Pharma Inc. | Antifungal pharmaceutical composition |
WO2009031643A1 (ja) | 2007-09-05 | 2009-03-12 | Pola Pharma Inc. | 抗真菌組成物 |
WO2009031642A1 (ja) | 2007-09-05 | 2009-03-12 | Pola Pharma Inc. | 医薬組成物 |
JP5654497B2 (ja) * | 2009-02-13 | 2015-01-14 | トピカ ファーマシューティカルズ,インコーポレイテッド | 抗真菌製剤 |
JP5688406B2 (ja) | 2009-04-09 | 2015-03-25 | 株式会社ポーラファルマ | 抗真菌医薬組成物 |
JP5688405B2 (ja) | 2009-04-09 | 2015-03-25 | 株式会社ポーラファルマ | 抗真菌医薬組成物 |
WO2011024620A1 (en) * | 2009-08-25 | 2011-03-03 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
KR101806304B1 (ko) * | 2010-06-11 | 2017-12-07 | 가부시키가이샤 폴라 파마 | 항진균성 약학적 조성물 |
CN103012385B (zh) * | 2012-02-17 | 2015-07-08 | 山东威智医药工业有限公司 | 卢立康唑的晶型及其制备方法 |
WO2014041846A1 (en) * | 2012-09-14 | 2014-03-20 | Pola Pharma Inc. | Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and phrmaceutical composition prepared by containing the crystal |
JP5460797B1 (ja) | 2012-09-14 | 2014-04-02 | 株式会社ポーラファルマ | アミド誘導体及び安定性指標としてのその使用 |
IN2015DN02376A (ja) * | 2012-09-14 | 2015-09-04 | Pola Pharma Inc | |
EP2895165B1 (en) * | 2012-09-14 | 2016-12-14 | Pola Pharma Inc. | Crystal and pharmaceutical preparation containing the same crystal |
CN104955455A (zh) * | 2013-01-28 | 2015-09-30 | 宝丽制药股份有限公司 | 针对由病原微生物诸如曲霉引起的疾病的药物组合物 |
US20150352078A1 (en) * | 2013-01-28 | 2015-12-10 | Pola Pharma Inc. | Pharmaceutical composition for diseases caused by pathogenic microorganisms such as candida |
JP5589110B1 (ja) | 2013-03-08 | 2014-09-10 | 株式会社ポーラファルマ | 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物 |
JP5680161B1 (ja) | 2013-09-06 | 2015-03-04 | 株式会社ポーラファルマ | 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物 |
JP5587488B1 (ja) | 2013-12-12 | 2014-09-10 | 株式会社ポーラファルマ | ルリコナゾールを含有する製剤の評価方法及び指標物質 |
AR100180A1 (es) * | 2014-04-25 | 2016-09-14 | Syngenta Participations Ag | Derivados de imidazol microbiocidas |
US10703744B2 (en) * | 2014-12-12 | 2020-07-07 | Glenmark Life Sciences Limited | Process for preparation of luliconazole |
WO2017108972A1 (en) | 2015-12-21 | 2017-06-29 | Laboratorios Lesvi, S.L. | Compounds of r-(-)-(e)-[4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-1 -imidazolylacetonitrile-ha (luliconazole-ha) as antifungals |
CN106008166B (zh) * | 2016-05-17 | 2018-09-25 | 上海福乐医药科技有限公司 | 一种手性2-氯-1-(2,4-二氯苯基)乙醇的工业化生产方法 |
US11185548B2 (en) | 2016-12-23 | 2021-11-30 | Helmholtz Zentrum Munchen—Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) | Inhibitors of cytochrome P450 family 7 subfamily B member 1 (CYP7B1) for use in treating diseases |
TR201714882A2 (tr) | 2017-10-03 | 2019-04-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Luli̇konazolün topi̇kal farmasöti̇k kompozi̇syonlari |
US10898470B1 (en) | 2019-08-13 | 2021-01-26 | Sato Pharmaceutical Co., Ltd. | Pharmaceutical composition containing antifungal agent as active ingredient |
WO2023131969A1 (en) * | 2022-01-09 | 2023-07-13 | Kimia Biosciences Limited | Improved process for the preparation of luliconazole |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0218736B1 (en) * | 1985-10-10 | 1993-04-07 | Nihon Nohyaku Co., Ltd. | A ketene s,s-acetal derivative, a process for manufacturing thereof and a method for curing mycosis by administering it |
ATE87920T1 (de) * | 1985-10-09 | 1993-04-15 | Nihon Nohyaku Co Ltd | Keten-s,s,-acetalderivate, verfahren zu ihrer herstellung und methode zur heilung von mykose unter verwendung dieser derivate. |
JP3030780B2 (ja) * | 1988-12-29 | 2000-04-10 | 日本農薬株式会社 | 光学活性なケテンジチオアセタール誘導体及びその製造方法 |
JPH0386337A (ja) * | 1989-08-28 | 1991-04-11 | Maeda Seisakusho:Kk | エクスパンディングチャックを用いた多重巻締め機および多重巻締め方法 |
CN1038247C (zh) * | 1990-05-16 | 1998-05-06 | 云南省建筑材料科学研究设计院 | 一种新型磷石膏胶结料 |
JP3038519B2 (ja) * | 1992-01-28 | 2000-05-08 | 日本農薬株式会社 | 創傷治癒促進剤 |
-
1996
- 1996-07-05 CH CH00023/98A patent/CH692045A5/de not_active IP Right Cessation
- 1996-07-05 CN CN96196659A patent/CN1091596C/zh not_active Expired - Lifetime
- 1996-07-05 EP EP96922243A patent/EP0839035B1/en not_active Expired - Lifetime
- 1996-07-05 IL IL12261896A patent/IL122618A/en not_active IP Right Cessation
- 1996-07-05 GB GB9726766A patent/GB2317615B/en not_active Expired - Lifetime
- 1996-07-05 AT AT0906196A patent/AT407832B/de not_active IP Right Cessation
- 1996-07-05 NZ NZ311796A patent/NZ311796A/xx not_active IP Right Cessation
- 1996-07-05 WO PCT/JP1996/001872 patent/WO1997002821A2/en active IP Right Grant
- 1996-07-05 US US08/981,420 patent/US5900488A/en not_active Expired - Lifetime
- 1996-07-05 ZA ZA965745A patent/ZA965745B/xx unknown
- 1996-07-05 IN IN1499DE1996 patent/IN185384B/en unknown
- 1996-07-05 DE DE19681478T patent/DE19681478B4/de not_active Expired - Lifetime
- 1996-07-05 CA CA002226214A patent/CA2226214C/en not_active Expired - Lifetime
- 1996-07-05 ES ES009750013A patent/ES2137888B1/es not_active Expired - Fee Related
- 1996-07-05 KR KR10-1998-0700071A patent/KR100386491B1/ko not_active IP Right Cessation
- 1996-07-06 TW TW085108169A patent/TW450969B/zh not_active IP Right Cessation
-
1997
- 1997-12-31 LU LU90190A patent/LU90190B1/de active
-
1998
- 1998-01-06 NO NO980055A patent/NO980055L/no not_active Application Discontinuation
- 1998-01-07 DK DK199800013A patent/DK176599B1/da not_active IP Right Cessation
- 1998-01-07 SE SE9800016A patent/SE9800016D0/xx not_active Application Discontinuation
- 1998-01-07 FI FI980023A patent/FI119357B/fi not_active IP Right Cessation
- 1998-09-18 HK HK98110741A patent/HK1009751A1/xx not_active IP Right Cessation